James Poupalos
NPI: 1912393133
Total Payments
$930.23
2024 Payments
$458.89
Companies
8
Transactions
55
Medicare Patients
2,105
Medicare Billing
$124,347
Payment Breakdown by Category
Food & Beverage$918.52 (98.7%)
Education$11.71 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $918.52 | 54 | 98.7% |
| Education | $11.71 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $254.22 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $180.21 | 6 | $0 (2024) |
| PFIZER INC. | $141.12 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $123.31 | 12 | $0 (2023) |
| Novo Nordisk Inc | $112.70 | 7 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $73.03 | 5 | $0 (2024) |
| Amgen Inc. | $31.60 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $14.04 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $458.89 | 22 | AstraZeneca Pharmaceuticals LP ($180.21) |
| 2023 | $292.31 | 17 | Lilly USA, LLC ($104.34) |
| 2022 | $25.09 | 2 | Lilly USA, LLC ($25.09) |
| 2021 | $17.55 | 1 | Lilly USA, LLC ($17.55) |
| 2019 | $110.32 | 11 | Janssen Pharmaceuticals, Inc ($110.32) |
| 2018 | $26.07 | 2 | PFIZER INC. ($26.07) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.09 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Inflammation | ||||||
| 06/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Diabetes | ||||||
| 06/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Respiratory | ||||||
| 06/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/08/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Respiratory | ||||||
| 04/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.32 | General |
| Category: Cardiovascular | ||||||
| 04/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Diabetes | ||||||
| 02/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Obesity | ||||||
| 01/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug), FARXIGA, AIRSUPRA | Food and Beverage | In-kind items and services | $104.73 | General |
| Category: Respiratory | ||||||
| 12/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Cardiovascular | ||||||
| 11/17/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Inflammation | ||||||
| 10/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 549 | 676 | $64,718 | $35,013 |
| 2022 | 18 | 595 | 710 | $66,006 | $35,583 |
| 2021 | 19 | 537 | 656 | $69,521 | $33,267 |
| 2020 | 13 | 424 | 500 | $47,677 | $20,483 |
Total Patients
2,105
Total Services
2,542
Medicare Billing
$124,347
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 146 | $22,046 | $12,382 | 56.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $23,500 | $11,766 | 50.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 15 | $4,975 | $2,972 | 59.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $2,250 | $2,014 | 89.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 19 | $1,900 | $1,077 | 56.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 54 | 74 | $2,146 | $970.88 | 45.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $1,147 | $855.79 | 74.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 54 | 75 | $1,725 | $776.25 | 45.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 33 | 41 | $1,476 | $674.86 | 45.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 18 | 19 | $1,425 | $551.19 | 38.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 52 | 66 | $1,122 | $502.26 | 44.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 28 | $588.00 | $266.56 | 45.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 19 | 19 | $228.00 | $107.54 | 47.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 19 | 19 | $190.00 | $96.52 | 50.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 96 | 96 | $24,100 | $12,043 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 124 | $18,724 | $10,491 | 56.0% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2022 | 14 | 14 | $4,550 | $3,137 | 68.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $3,262 | $1,619 | 49.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $1,800 | $1,576 | 87.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $2,000 | $1,318 | 65.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 57 | 70 | $2,030 | $924.97 | 45.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 60 | 75 | $1,725 | $781.40 | 45.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $1,036 | $769.50 | 74.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 33 | 42 | $1,512 | $696.08 | 46.0% |
| 82306 | Vitamin d-3 level | Office | 2022 | 23 | 23 | $1,725 | $671.03 | 38.9% |
About James Poupalos
James Poupalos is a Student in an Organized Health Care Education/Training Program healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1912393133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Poupalos has received a total of $930.23 in payments from pharmaceutical and medical device companies, with $458.89 received in 2024. These payments were reported across 55 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($918.52).
As a Medicare-enrolled provider, Poupalos has provided services to 2,105 Medicare beneficiaries, totaling 2,542 services with total Medicare billing of $124,347. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Williamsville, NY
- Active Since 04/14/2015
- Last Updated 12/07/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1912393133
Products in Payments
- ELIQUIS (Drug) $175.37
- XARELTO (Drug) $123.31
- BREZTRI (Drug) $118.66
- EMGALITY (Drug) $86.87
- TRULICITY (Drug) $66.80
- Rybelsus (Drug) $49.75
- Ozempic (Drug) $48.10
- AIRSUPRA (Drug) $44.74
- JARDIANCE (Drug) $38.50
- MOUNJARO (Drug) $33.74
- Otezla (Drug) $31.60
- CHANTIX (Drug) $26.07
- FARXIGA (Drug) $16.81
- ZEPBOUND (Drug) $16.60
- TRELEGY ELLIPTA (Drug) $14.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Williamsville
Ryan Denhaese, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $2.7M
Student in an Organized Health Care Education/Training Program $2.7M
James Aitken
Student in an Organized Health Care Education/Training Program — Payments: $35,216
Student in an Organized Health Care Education/Training Program $35,216
Jack Route, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $16,044
Student in an Organized Health Care Education/Training Program $16,044
Dr. Scott Sobieraj, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,279
Student in an Organized Health Care Education/Training Program $4,279
Ndey Diallo, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,211
Student in an Organized Health Care Education/Training Program $4,211
Scott Pollack, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $3,825
Student in an Organized Health Care Education/Training Program $3,825